Axsome Therapeutics (AXSM) EPS (Basic) Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 139.68% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 25.99% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 41.58% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.28% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 58.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -2.92% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.92% |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn | -69.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -69.23% |
| Dec 31, 2025 | 27.28% |
| Sep 30, 2025 | 4.23% |
| Jun 30, 2025 | 2.91% |
| Mar 31, 2025 | -4.80% |
| Dec 31, 2024 | -19.61% |
| Sep 30, 2024 | -12.95% |
| Jun 30, 2024 | -24.76% |
| Mar 31, 2024 | -22.67% |
| Dec 31, 2023 | -39.18% |
| Sep 30, 2023 | -29.34% |
| Jun 30, 2023 | -46.48% |
| Mar 31, 2023 | 33.40% |
| Dec 31, 2022 | -26.29% |
| Sep 30, 2022 | -24.09% |
| Jun 30, 2022 | -37.25% |
| Mar 31, 2022 | -49.07% |
| Dec 31, 2021 | -41.16% |
| Sep 30, 2021 | -44.22% |
| Jun 30, 2021 | -39.03% |
| Mar 31, 2021 | -60.12% |
| Dec 31, 2020 | -36.59% |
| Sep 30, 2020 | -31.22% |
| Jun 30, 2020 | -17.77% |
| Mar 31, 2020 | -28.99% |
| Dec 31, 2019 | -23.17% |
| Sep 30, 2019 | -13.80% |
| Jun 30, 2019 | -4.43% |
| Mar 31, 2019 | -1.06% |
| Dec 31, 2018 | -11.64% |
| Sep 30, 2018 | 8.90% |
| Jun 30, 2018 | -18.98% |
| Mar 31, 2018 | 0.00% |